| Development of novel tetravalent anti-CD20 antibodies with potent antitumor activity B Li, S Shi, W Qian, L Zhao, D Zhang, S Hou, L Zheng, J Dai, J Zhao, ... Cancer research 68 (7), 2400-2408, 2008 | 102 | 2008 |
| Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma B Li, L Zhao, H Guo, C Wang, X Zhang, L Wu, L Chen, Q Tong, W Qian, ... Blood 114 (24), 5007-5015, 2009 | 89 | 2009 |
| A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo J Dai, B Li, J Shi, L Peng, D Zhang, W Qian, S Hou, L Zhao, J Gao, Z Cao, ... Cancer immunology, immunotherapy 59 (3), 355-366, 2010 | 78 | 2010 |
| Bispecific antibody to ErbB2 overcomes trastuzumab resistance through comprehensive blockade of ErbB2 heterodimerization B Li, Y Meng, L Zheng, X Zhang, Q Tong, W Tan, S Hu, H Li, Y Chen, ... Cancer research 73 (21), 6471-6483, 2013 | 73 | 2013 |
| Suppression of Tumor Growth and Metastasis by Simultaneously Blocking Vascular Endothelial Growth Factor (VEGF)–A and VEGF-C with a Receptor-Immunoglobulin Fusion Protein D Zhang, B Li, J Shi, L Zhao, X Zhang, C Wang, S Hou, W Qian, G Kou, ... Cancer research 70 (6), 2495-2503, 2010 | 69 | 2010 |
| Fine epitope mapping of humanized anti-IgE monoclonal antibody omalizumab L Zheng, B Li, W Qian, L Zhao, Z Cao, S Shi, J Gao, D Zhang, S Hou, ... Biochemical and biophysical research communications 375 (4), 619-622, 2008 | 44 | 2008 |
| Identification of a novel functional domain of ricin responsible for its potent toxicity J Dai, L Zhao, H Yang, H Guo, K Fan, H Wang, W Qian, D Zhang, B Li, ... Journal of Biological Chemistry 286 (14), 12166-12171, 2011 | 43 | 2011 |
| A bispecific antibody effectively inhibits tumor growth and metastasis by simultaneous blocking vascular endothelial growth factor A and osteopontin G Kou, J Shi, L Chen, D Zhang, S Hou, L Zhao, C Fang, L Zheng, X Zhang, ... Cancer letters 299 (2), 130-136, 2010 | 30 | 2010 |
| Immunoglobulin Gamma-Like Therapeutic Bispecific Antibody Formats for Tumor Therapy S Chen, L Li, F Zhang, Y Wang, Y Hu, L Zhao Journal of Immunology Research 2019, 2019 | 27 | 2019 |
| Construction and characterization of a high-affinity humanized SM5-1 monoclonal antibody B Li, H Wang, D Zhang, W Qian, S Hou, S Shi, L Zhao, G Kou, Z Cao, ... Biochemical and biophysical research communications 357 (4), 951-956, 2007 | 26 | 2007 |
| The protein-protein interface evolution acts in a similar way to antibody affinity maturation B Li, L Zhao, C Wang, H Guo, L Wu, X Zhang, W Qian, H Wang, Y Guo Journal of Biological Chemistry 285 (6), 3865-3871, 2010 | 25 | 2010 |
| Eradication of non-Hodgkin lymphoma through the induction of tumor-specific T-cell immunity by CD20-Flex BiFP L Zhao, Q Tong, W Qian, B Li, D Zhang, T Fu, S Duan, X Zhang, J Zhao, ... Blood 122 (26), 4230-4236, 2013 | 21 | 2013 |
| Combating HER2-overexpressing breast cancer through induction of calreticulin exposure by Tras-Permut CrossMab F Zhang, J Zhang, M Liu, L Zhao, RX LingHu, F Feng, X Gao, S Jiao, ... OncoImmunology 4 (3), e994391, 2015 | 20 | 2015 |
| Anti-PD-1 therapy plus chemotherapy and/or bevacizumab as second line or later treatment for patients with advanced non-small cell lung cancer F Zhang, D Huang, T Li, S Zhang, J Wang, Y Zhang, G Wang, Z Zhao, ... Journal of Cancer 11 (3), 741, 2020 | 19 | 2020 |
| Efficacy and safety of PD-1/PD-L1 inhibitors plus nab-paclitaxel for patients with non-small cell lung cancer who have progressed after platinum-based chemotherapy F Zhang, D Huang, L Zhao, T Li, S Zhang, G Zhang, F Yuan, J Zhang, ... Therapeutic advances in medical oncology 12, 1758835920936882, 2020 | 17 | 2020 |
| Characterization of a humanized anti-CD20 antibody with potent antitumor activity against B-cell lymphoma L Wu, C Wang, D Zhang, X Zhang, W Qian, L Zhao, H Wang, B Li, Y Guo Cancer letters 292 (2), 208-214, 2010 | 17 | 2010 |
| Combating non-Hodgkin lymphoma by targeting both CD20 and HLA-DR through CD20–243 CrossMab L Zhao, F Xie, X Tong, H Li, Y Chen, W Qian, S Duan, J Zheng, Z Zhao, ... MAbs 6 (3), 739-747, 2014 | 16 | 2014 |
| Development and characterization of a fully functional small anti-HER2 antibody J Gao, B Li, H Li, X Zhang, D Zhang, L Zhao, C Wang, C Fang, W Qian, ... BMB Rep 42 (10), 636-641, 2009 | 11 | 2009 |
| Efficacy, safety and proper dose analysis of PEGylated granulocyte colony-stimulating factor as support for dose-dense adjuvant chemotherapy in node positive Chinese breast … F Zhang, R LingHu, X Zhan, R Li, F Feng, X Gao, L Zhao, J Yang Oncotarget, 2017 | 9 | 2017 |
| Clearance of Propionibacterium acnes by kupffer cells is regulated by osteopontin through modulating the expression of p47phox H Yang, H Guo, K Fan, B Zhang, L Zhao, S Hou, W Qian, D Zhang, ... Molecular immunology 48 (15), 2019-2026, 2011 | 9 | 2011 |
